Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 131,000 | 79,200 | 79,300 | 71,100 | 177,600 |
| Depreciation Amortization | 93,800 | 93,600 | 83,700 | 90,300 | 96,600 |
| Income taxes - deferred | 19,600 | 15,700 | 27,900 | 9,600 | 32,100 |
| Accounts receivable | -24,100 | 13,600 | -12,500 | 30,600 | -9,100 |
| Accounts payable and accrued liabilities | 36,500 | -13,400 | 20,700 | -28,300 | -1,300 |
| Other Working Capital | -72,200 | -67,400 | 19,700 | -19,000 | -125,400 |
| Other Operating Activity | -17,200 | 11,100 | -7,200 | -12,000 | -62,900 |
| Operating Cash Flow | $167,400 | $132,400 | $211,600 | $142,300 | $107,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -89,300 | -93,800 | -62,200 | -63,900 | -76,500 |
| Net Acquisitions | -4,600 | -101,600 | N/A | N/A | -1,000 |
| Purchase Of Investment | N/A | N/A | -500 | -1,000 | -2,500 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -9,000 | N/A |
| Other Investing Activity | 9,800 | 100 | 6,300 | -6,100 | 177,600 |
| Investing Cash Flow | $-84,100 | $-195,300 | $-56,400 | $-71,000 | $97,600 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -9,300 | -300 | N/A | N/A | N/A |
| Debt Issued | N/A | 198,900 | N/A | N/A | -102,900 |
| Debt Repayment | N/A | -100,000 | -7,400 | N/A | N/A |
| Common Stock Issued | 24,600 | 14,500 | 3,400 | 10,100 | 7,500 |
| Common Stock Repurchased | -13,100 | -27,700 | -32,700 | -52,300 | -63,100 |
| Dividend Paid | -15,700 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -7,100 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-20,600 | $85,400 | $-36,700 | $-42,200 | $-158,500 |
| Exchange Rate Effect | 10,000 | 18,600 | 7,900 | -2,300 | -1,900 |
| Beginning Cash Position | 251,100 | 210,000 | 83,600 | 56,800 | 12,000 |
| End Cash Position | 323,800 | 251,100 | 210,000 | 83,600 | 56,800 |
| Net Cash Flow | $72,700 | $41,100 | $126,400 | $26,800 | $44,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 167,400 | 132,400 | 211,600 | 142,300 | 107,600 |
| Capital Expenditure | -89,300 | -93,800 | -62,200 | -63,900 | -76,500 |
| Free Cash Flow | 78,100 | 38,600 | 149,400 | 78,400 | 31,100 |